Dynamics of minimal residual disease and its clinical implications in multiple myeloma: A retrospective real-life analysis

Background: Minimal residual disease (MRD) testing is a promising approach to tailor the treatment of multiple myeloma (MM). However, several major concerns remain to be addressed before moving it into daily practice, most of which stem from the dynamic nature of the MRD status. Thus, it is crucial...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Weiling Xu, Xinyue Liang, Shanshan Liu, Xingcheng Yi, Mengru Tian, Tingting Yue, Yingjie Zhang, Yurong Yan, Maozhuo Lan, Mengtuan Long, Nan Zhang, Jingxuan Wang, Xiaoxiao Sun, Rui Hu, Yufeng Zhu, Xintian Ma, Yue Cheng, Jiayi Xu, Yun Dai, Fengyan Jin
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2024-11-01
Ráidu:	Clinical Medicine
Fáttát:	Multiple myeloma Minimal residual disease Dynamics Relapse Outcome
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S147021182405437X
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!